Member Info for HedgeHogarth

Thanks Hookey - i don't tend to believe a lot o read on thos type of sites. Do you have any experience with them that is more positive?

I contacted the Fund Manager yesterday to enquire about the timing and decsion of the Cannacord disposal.

I got a reply - but sadly it is not something they share. (As expected, but if you dont try...)

I'm no sure the logic of you Cannacord theory works for me - I don't see how selling their shares at an avg of 11.5p does them any favours. Time will tell

I'm going to take a few more today at 10p if i can - absolute bargain IMO

I have shared some analysis and thoughts on X today

See link: https://twitter.com/Barneyboysrb/status/1752233100661170580

12.9m shares at a cost of £1.5m have been purchased in addition to the 1% we know was bought by Damian Hanson.

That's a lot of money and a lot of shares (12% of the company)

I'm curious to know whether someone has to notify when they have passed 1% if they have an order for a much bigger %. i.e. They have asked broker to go and secure them a 10% share in the company - can they wait until the 10% is filled?

Also interesting to note that if you add the share of the directors and founders together (and include options) they are not far off the 30% mark in which they may be asked to make an offer for all shares

There is a false narrative out there sadly - I saw something written up by Charles Archer. Whilst It talked very highly of Hemo, unfortunatlyit ended by saying it may be best to wait for the RNS given the recent rise in the share price. (i.e. people who sell the news)

The SP has gone up about 40-50% recently - but from a very low base.

I'm convinced that there will not be a chance to buy HEMO below 3p if the next RNS confirms that the clincial hold is lifted.

DYOR

Bad luck Davie_b - I did the same with FAB. I bought at 3.2p ad sold sub 4p :-(

Many years ago I did the same with UFO - Bought at 0.6p and sold just before it went to 2.5p!!!

RedOliv

My understanding of these RNS is:

Because Shore are have a client agreement with MMAG - they have to be transparent with their own dealings in the share

So these purchases and sales relate to Shore Capital; these do not relate to Music Magpie

I dont make anything up HT

Optimistically, I'm hoping that the FDA make an early decision and 'guessed'we make get an RNS later this week

However the 30 days does not finish until 14/15 Feb

Given how busy the FDA reportedly is - its far more likely that RNS lands week commencing 5th February

So - a pretty 'average' comment by HemoTruth - there is absolutely NO need to be worried at all if we don't get news this week.

ReOliv3 - MMAG have not bought any shares back - that would be something they would have to RNS

So...Cannacod have now disposed of their entire 12,146,044 shares - that equates to >11% of the MusicMagpie. In addition another 1% of the company (1,119,078 shares) was sold by Schroders

Yet - The only RNS we've have to show a new major holding was from Damian Hanson who ownes 1.1m shares.

So where have the other 12m gone??? (£1.2m worth)

That's a lot of share for private investors to snap up in the space of 6-8 weeks.

Who is Paul Scott?

I'm planning on doing some analysis later in the week

They achieved £45m Revenue in a year in whoch not all their estate was open for the whole 12mths and the Boom Bars are still maturing.

So for FY24 -

1- we could see +2-3% growth to reflect a full year of the current estate

2 - Perhaps 10% - L4L growth in Boom performance - more Corporate sales, maturing operations

3 - 'Up to 5%' from transitioning a small number of Franchises to owner operated

4 - 5% growth from adding new venues in 2024 (assume 5-10 new venues but the won't see a full year benefit n FY24)

So maybe +25% Revenue Growth fro me is very likely - but will do some more detailed anaylsis later in the week

That would equate to about £55-60m revenue with EBITDA in the region of c£10-15m

The company is cash generative

It makes the current mCap look very odd at just £26m - it also maked XP a sitting duck. I really do belive that their will be Private Equity eyeing this up.

Puttshack is owned by BlackRock who then handed the copnay $150m to fuel growth

Lovely late trade reported :-)

Oh, and on the Cannorcord piece - if it is their final 3% (The 3.2m shares today) - who has bought them??????

@Redolive

To change the ownership structure something has to give. At the starts of December there was barely 6m shares in circulation

I dont quite know exactly waht is going on - but I'm very sure that these disposals are not just standards sells.

I see a 3.2m shares transacted today in two lumps - Thats 3% of the company.

It could be the last of Cannacord or it could be purchses by a potential suitor - particularly given it adds up close to 3%

Exciting times

Don't be a dikk @Pumpky

I don't post things that I do not believe

FDA has committed to providing a scheduled date for 90 percent of post-CRL clarification teleconferences within 14 calendar days of a written request.

However, on further investigation. The CRL (Complete Response Letter) is actually the letter that the FDA sent to Hemo to explain their decision and feedback from the original review.

So - I retract, Vlad probably does not know yet. He will get a call anytime in the 30 days

By now, Vlad almost certainly will know the date on which the FDA will communciate their feedback

I'll get str8 to the point, this board already has my views on XP Factory :-)

There appears to be a very big spread right now - the Bid and Ask are often well beyond what you actually pay or get paid for a share. The genuine spread is also very large; yesterday was 0.75p which is 5% - this is very high.

The above leads me to think that there is a Big order being filled; low did to attract sellers, high Ask to dissuade buyers.

AIMO, DYOR

RedOlive - Be careful, I do not believe your last statemnet is factual

It's impossible to tell what is a buy and what is a sell - regardless of the price

We know from the 8.3 a few weeks ago that there was a big 1m purchase at 11p - so if any orders are being filled they could well be around that price.

Its all smoke and mirrors

Lets not get into a conversation about HemoTruth

Hemogenyx are on the cusp of something very special - lets stick to talking about the company

I happen to beleive that Hemotruth probably does have a decent holding; but I also beleive he trades the share regularly, perhaps with shares in a different pot. He's been here for years; I do with he was a put more positive at times, but ultimately that is his prerogative. My only regret is his relunctance to 'connect,' I'd welcome a quick call with him from time to time - and he also blocked me from Twitter becuase we differ in approach of how to engage the company.

So - back to business

I never expected the FDA news to come this week - it felt a little too soon. However, I do think that next week represents a very realistic prospect of getting news - The FDA are not starting from scratch, the team reviewing the IND have already reviewed the first draft AND approved in principle the plan that Hemo proposed to clear the Clincial Hold.

Come on 1st Feb :-)

Very doubtful - I tried a dummy sell and only offer 11.6ish